Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cannabis in Bipolar Disorder and Healthy Volunteers
NCT04231643Phase 1Terminated
- Sponsor
- University of California, San Diego
- Start
- Sep 2021
- Primary completion
- Nov 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of dronabinol and cannabidiol in bipolar disorder (BD) (2 arms), sponsored by University of California, San Diego. Primary endpoints: Score on Iowa Gambling Task, Score on Progressive Ratio Test and 6 more. Started Sep 2021; status: terminated.
02
Drugs
dronabinolcannabidiol
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on NCT04231643.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04231643.